BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12765846)

  • 1. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation.
    Lindi V; Schwab U; Louheranta A; Laakso M; Vessby B; Hermansen K; Storlien L; Riccardi G; A Rivellese A;
    Mol Genet Metab; 2003 May; 79(1):52-60. PubMed ID: 12765846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels.
    Layne KS; Goh YK; Jumpsen JA; Ryan EA; Chow P; Clandinin MT
    J Nutr; 1996 Sep; 126(9):2130-40. PubMed ID: 8814201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene in healthy individuals.
    Vaccaro O; Mancini FP; Ruffa G; Sabatino L; Iovine C; Masulli M; Colantuoni V; Riccardi G
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):481-6. PubMed ID: 12354130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
    Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
    Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.
    Stark KD; Park EJ; Maines VA; Holub BJ
    Am J Clin Nutr; 2000 Aug; 72(2):389-94. PubMed ID: 10919932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
    Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
    González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
    Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype.
    Minihane AM; Khan S; Leigh-Firbank EC; Talmud P; Wright JW; Murphy MC; Griffin BA; Williams CM
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1990-7. PubMed ID: 10938022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients.
    Goh YK; Jumpsen JA; Ryan EA; Clandinin MT
    Diabetologia; 1997 Jan; 40(1):45-52. PubMed ID: 9028717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.
    Buckley R; Shewring B; Turner R; Yaqoob P; Minihane AM
    Br J Nutr; 2004 Sep; 92(3):477-83. PubMed ID: 15469651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype.
    Wu SY; Mayneris-Perxachs J; Lovegrove JA; Todd S; Yaqoob P
    Am J Clin Nutr; 2014 Nov; 100(5):1232-43. PubMed ID: 25332321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish oil supplementation attenuates changes in plasma lipids caused by dexamethasone treatment in rats.
    Barbosa AM; Francisco Pde C; Motta K; Chagas TR; Dos Santos C; Rafacho A; Nunes EA
    Appl Physiol Nutr Metab; 2016 Apr; 41(4):382-90. PubMed ID: 26939043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
    Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
    Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation with saury oil, a fish oil high in omega-11 monounsaturated fatty acids, improves plasma lipids in healthy subjects.
    Yang ZH; Amar M; Sorokin AV; Troendle J; Courville AB; Sampson M; Playford MP; Yang S; Stagliano M; Ling C; Donkor K; Shamburek RD; Mehta NN; Remaley AT
    J Clin Lipidol; 2020; 14(1):53-65.e2. PubMed ID: 31784345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol.
    Maki KC; Van Elswyk ME; McCarthy D; Hess SP; Veith PE; Bell M; Subbaiah P; Davidson MH
    J Am Coll Nutr; 2005 Jun; 24(3):189-99. PubMed ID: 15930485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
    Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
    Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.